A golden era for blood cancer treatments

It’s an exciting time in blood cancer research. As we deepen our understanding of the biology of blood cancer, researchers are developing better treatments than ever before, and we’re even beginning to talk about...

The search for new antimicrobials

Few issues are more pressing than the global problem of antibiotic resistance, so we speak to Professor Mathew Upton, about his work searching for new antibiotics. “For so long now, antibiotics have been seen as...

New research predicts a positive future for biosimilars

The prospect of reducing treatment costs for payors supports a positive future for biosimilars Biosimilar approvals in the US market still significantly lag behind Europe despite an evolving regulatory landscape and three new...

Supercharged natural killer cells may hold promise for cancer

A type of ‘supercharged’ immune cell could be mass-produced to help fight cancer. The researchers behind the early-stage finding, from Imperial College London, say the development could mark the next generation of cutting-edge immunotherapy treatments,...

How chromosomes find a happy medium

By Sabrina Richards Staff writer at Fred Hutchinson Cancer Research Center Hutch scientists show how chromosomes communicate to balance crossovers during sex-cell formation Scientists at Fred Hutchinson Cancer Research Center have worked out the molecular underpinnings of...

Stanford shows that breast cancers punch tunnels into neighbouring tissue

Stanford researchers have found that malignant breast cancer cells can extend protrusions known as invadopodia to dig escape tunnels through surrounding tissue, revealing a possible new target for therapies. Cancers pose the greatest danger when...

Combatting antibiotic resistance

In the UK alone, the government estimates there are currently 5,000 deaths each year because antibiotics no longer work for some infections. Worldwide, drug-resistant infections are set to kill more people than cancer and...

Over three million surgical operations and cancer treatments a year in England may become...

New data published by Public Health England (PHE) show that antibiotic resistant bloodstream infections continue to rise in England, with an estimated 35% increase from 2013 to 2017 (from 12,250 in 2013 to...

90 years on, the time-bomb of antibiotic resistance

By Professor Colin Garner The events of 28 September 1928 could justifiably lay claim to being called the most significant breakthrough in medical history. With typical ingenuity and a quantity of genius, Sir Alexander Fleming discovered...

90 years since Sir Alexander Fleming’s penicillin discovery changed antibiotic treatment

“My name is Sarah Whitlow and my paternal grandfather was Sir Alexander Fleming, who discovered penicillin. I have worked as a practice nurse at the Swan Surgery in Bury St Edmunds, Suffolk, since 1990,...

Artificial Neural Networks working with Image Guided Therapies to improve heart disease treatment

By Rashed Karim Research Fellow at King’s College London School of Biomedical Engineering and Imaging Sciences It’s exciting to envisage that future treatments for cardiovascular disease will be supported by intelligent systems and devices. At the...

Simplicity is all

In this issue of BioScience Today, Ellen Rossiter speaks to Professor Kawal Rhode about his work in the realm of biomedical engineering, his inspiration, motivation and why simplicity is all. “Way back in school, we...

Research finds three major failings in some apps used for the diagnosis of skin...

In the scramble to bring successful apps for the diagnosis of skin cancer to market there is a concern that a lack of testing is risking public safety, according to research led by the...

Research reveals how Tau aggregates can contribute to cell death in Alzheimer’s disease

New evidence suggests a mechanism by which progressive accumulation of Tau protein in brain cells may lead to Alzheimer’s disease. Scientists studied more than 600 human brains and fruit fly models of Alzheimer’s disease...

Focus on Alzheimer’s disease 
– Hope on the horizon

Dr David Reynolds Chief Scientific Officer at Alzheimer’s Research UK Alzheimer’s Research UK is the UK’s leading dementia research charity and is dedicated to funding pioneering research to find ways to understand, diagnose, reduce risk and...

Research offers hope

There is hope in the battle against drug-resistant drugs, though. For example, a newly discovered antibiotic, produced by bacteria from a cystic fibrosis patient, could be used to treat cases of drug-resistant tuberculosis (TB),...